- Home
- J&J Innovative Medicine
J&J Innovative Medicine
What you need to know about Johnson & Johnson’s 2018 third-quarter earnings
Learn how the company’s consumer, pharmaceutical and medical devices businesses performed in the third quarter of 2018 in this snapshot of its latest earnings report.
“I have autism—and it’s a big reason why I’m successful.”
For National Autism Awareness Month, Angela Andrews, a data manager at Janssen, shares her personal journey living and thriving with autism—and advocating for others just like her.
The quest to end tuberculosis: 17 memorable moments in innovation
Johnson & Johnson has been instrumental in helping bring us closer to a TB-free world through its groundbreaking work with multidrug-resistant TB.
Meet one of Johnson & Johnson’s very own pandas
He may not wear a lab coat, but Johnson & Johnson (that’s his name!) is a member of the family, thanks to a conservation partnership between Xian Janssen and the Shaanxi Academy of Forestry Qinling Mountains Giant Panda Breeding Center. We catch up with the mischievous youngster on the anniversary of his adoption ceremony.
4 questions for immunotherapy pioneer Dr. James Allison
We sat down with the winner of the 2018 Dr. Paul Janssen Award for Biomedical Research to learn how his tireless cancer research efforts have helped revolutionize the way we treat the disease—and save lives.
4 questions for a scientist working on a revolutionary CAR-T therapy for multiple myeloma
Johnson & Johnson and Chinese company Legend Biotech have teamed up to work on a new form of treatment for the incurable blood cancer. We interview Dr. Sen Zhuang about the unique collaboration—and the promise it holds.
“I am a triathlete with Crohn’s disease": Meet a man who’s been living and thriving with inflammatory bowel disease for half his life
Tackling a triathlon isn’t for the faint of heart. But Mark van Ooij, an Associate Scientific Director for Janssen Vaccines & Prevention B.V., is doing just that—and he’s taking what he’s learned from his disease to propel him forward.
Meet a Johnson & Johnson researcher poised to crack the HIV vaccine code
In the lead-up to the recent International AIDS Society Conference on HIV Science in the Netherlands, we sat down with Hanneke Schuitemaker, who’s hard at work on the holy grail of HIV research: a preventive treatment.
What you need to know about Johnson & Johnson’s 2018 second-quarter earnings
In this recap of Johnson & Johnson’s latest earnings report, you can learn how the company’s consumer, pharmaceutical and medical devices businesses performed in the second quarter of 2018.
“Johnson & Johnson helped me transition": Meet an employee who’s now living his true self.
For International Transgender Day of Visibility, Clark Musto shares his inspiring story—one made possible, in part, due to the support he received at work.